Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 | Zendy

Ф. У. Дзгоева | Zendy; О. В. Ремизов | Zendy; Victoria Kh. Botcieva | Zendy; V. G. Goloeva | Zendy; N. G. Malakhova | Zendy; Z. R. Ikoeva | Zendy

Open Access

Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5

Author(s) -

Ф. У. Дзгоева,

О. В. Ремизов,

Victoria Kh. Botcieva,

V. G. Goloeva,

N. G. Malakhova,

Z. R. Ikoeva

Publication year - 2022

Publication title -

terapevticheskii arkhiv

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.181

H-Index - 14

eISSN - 2309-5342

pISSN - 0040-3660

DOI - 10.26442/00403660.2022.06.201562

Subject(s) - medicine , sclerostin , stage (stratigraphy) , clinical significance , kidney disease , calcification , disease , pathology , gastroenterology , biochemistry , wnt signaling pathway , biology , gene , paleontology , chemistry

To clarify the mechanisms of the effect of osteoprotegerin (OPG) and sclerostin on vascular calcification and the state of the cardiovascular system in chronic kidney disease (CKD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research